Hypercortisolism: An Under‐Recognised Pathway Linked to Multi‐System Complications
Diabetes, Obesity and Metabolism · 2026
DOI: 10.1111/dom.71149 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Hernan Daniel Sacoto und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA. Hauptthemen laut MEDLINE: Cushing Syndrome. Die Arbeit nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The clinical understanding of hypercortisolism (HC) has evolved from a classic overt syndrome with florid Cushingoid features to a broader spectrum of disease that includes milder presentations, often referred to as mild autonomous cortisol secretion (MACS). This shift has lowered the threshold for screening and encouraged clinicians to consider HC even in the absence of classic physical findings, particularly in patients presenting with common features, including metabolic, cardiovascular, musculoskeletal and neuropsychiatric comorbidities. Chronic cortisol excess is associated with substantial morbidity and increased mortality through widespread effects on glucose metabolism, lipid homeostasis, cardiovascular function, blood pressure control, bone and muscle health, reproductive function, cognition and mental health. Importantly, many of these complications are frequently seen in patients with MACS, particularly in association with difficult‐to‐control diabetes and hypertension, emphasising the importance of earlier disease recognition. Recent data suggest that this abnormality may be more common than previously recognised, and its identification can have important implications for patient management. Emerging evidence may also help identify individuals at higher risk through relatively simple screening tests. Recognising this abnormality, particularly in patients with common chronic diseases that are difficult to control, represents a novel and clinically important concept that may lead to more targeted evaluation and management strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA.
ORCID-Profile: Vivian A Fonseca
Zitieren
APA
Sacoto, H. D., & Fonseca, V. A. (2026). Hypercortisolism: An Under‐Recognised Pathway Linked to Multi‐System Complications. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71149
Vancouver
Sacoto HD, Fonseca VA. Hypercortisolism: An Under‐Recognised Pathway Linked to Multi‐System Complications. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.71149
BibTeX
@article{Sacoto2026,
author = {Sacoto, Hernan Daniel and Fonseca, Vivian A},
title = {Hypercortisolism: An Under‐Recognised Pathway Linked to Multi‐System Complications},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
doi = {10.1111/dom.71149}
}
EUVIMED